HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

7th Edition of Cardiology World Conference

October 08-10, 2026 | Tokyo, Japan

October 08 -10, 2026 | Tokyo, Japan

Mitral Valve Prolapse

Mitral Valve Prolapse

Mitral Valve Prolapse (MVP) is a prevalent cardiovascular condition characterized by an abnormal closure of the mitral valve, the valve situated between the heart's left atrium and ventricle. In MVP, the valve's leaflets exhibit an unusual bulging or backward collapse into the atrium, leading to blood regurgitation. While some individuals with MVP remain asymptomatic, others may present with symptoms such as chest discomfort, palpitations, or persistent fatigue. The precise etiology of MVP is often elusive, although it can be linked to certain connective tissue disorders. Echocardiography is the primary diagnostic tool for evaluating MVP, enabling a detailed assessment of the mitral valve's structure and functionality. Treatment is generally unnecessary for those without symptomatic manifestations, but individuals with severe cases might be advised to undergo medication therapy. In rare instances, surgical intervention may be considered to repair or replace the affected valve. Regular monitoring and consistent communication with healthcare providers are crucial for the effective management of Mitral Valve Prolapse.

Submit your abstract Today

Watsapp